Quantcast

Latest stroke Stories

2014-03-25 23:36:17

The DrugRisk Center is the Web’s largest source for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) March 25, 2014 The prescription drug safety advocates at DrugRisk.com have added the latest information to the site for testosterone warnings and legal news. Experts have called for new warnings on popular low-T drugs after studies show they may cause heart attacks or stroke*. DrugRisk is a free resource providing...

2014-03-25 23:32:12

The globally standardized certification methodology is now accepted across healthcare organizations, clinical trial sponsors, CROs and regulatory agencies. Austin, TX (PRWEB) March 25, 2014 More than 500,000 healthcare and clinical research professionals in 164 countries representing every continent have been trained and certified on the NIH Stroke Scale (NIHSS) and can now share their standardized certifications electronically across employees, sponsors and clinical trials via HCP’s...

2014-03-24 23:28:48

National network of attorneys follows up on substantial number of consumer inquiries into no-cost consultations in connection with FDA announcement of review of testosterone treatments. San Diego, CA (PRWEB) March 24, 2014 http://www.resource4thepeople.com/defectivedrugs/testosteronetreatments-lawsuits.html Resource4thePeople announced today that its national team of lawyers will now be available to file lawsuits over allegations of heart attacks and strokes from testosterone treatment as...

2014-03-24 20:23:53

Second Generation drug coated balloon designed to address both acute and long-term outcomes PLEASANTON Calif. and SINGAPORE, March 24, 2014 /PRNewswire/ -- TriReme Medical LLC, a subsidiary of Singapore based QT Vascular Ltd. announced today that the first three patients were enrolled in a clinical study of its unique drug-coated Chocolate® PTA balloon. Dr. Andrew Holden, co-Principal Investigator of the study, performed these procedures at Auckland City Hospital, in Auckland, New...

2014-03-24 20:23:44

The International Society on Thrombosis and Haemostasis partners with thrombosis related organizations from every continent to launch World Thrombosis Day focused on single cause of top 3 cardiovascular deaths worldwide CHAPEL HILL, N.C., March 24, 2014 /PRNewswire-USNewswire/ -- Bringing together nations and local communities to tackle thrombosis, the quiet, underlying disorder that is the common mechanism of the world's three top cardiovascular killers - heart attack, stroke and venous...

2014-03-24 08:28:21

Presentations to include research around antidote for dabigatran, a post-hoc analysis of data from the RE-LY® trial and data from the GLORIA(TM)-AF registry RIDGEFIELD, Conn., March 24, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from three company-sponsored PRADAXA studies will be presented at the American College of Cardiology 63(rd) Annual Scientific Session (ACC.14) in Washington, D.C., March 29 to 31, 2014. An oral presentation will...

2014-03-24 08:27:40

- Subgroup analyses of East Asian populations from two phase 3 studies, ENGAGE AF-TIMI 48 and Hokusai-VTE, showed consistent results compared to the global study populations from these trials(1,2,3,4) TOKYO, March 24, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced late-breaking data from two pre-specified subgroup analyses of East Asian patients with non-valvular atrial fibrillation (NVAF) or venous thromboembolism (VTE) enrolled in two phase...

2014-03-24 08:26:49

Results Show Highest Rate of Control Ever Observed with Warfarin in Real-world Setting, Surpassing Thresholds for Cost-Effectiveness of Newer Agents Identified in Five Recent Independent Studies WALTHAM, Mass., March 24, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) today announced the publication of the largest-ever study of warfarin patient self-testing, which demonstrated that weekly International Normalized Ratio (INR) testing significantly improves control of warfarin, as measured...

Individualized Stroke Care From Bedside Optical Monitoring Of Cerebral Blood Flow
2014-03-23 14:12:57

University of Pennsylvania School of Medicine Using a University of Pennsylvania-designed device to noninvasively and continuously monitor cerebral blood flow (CBF) in acute stroke patients, researchers from Penn Medicine and the Department of Physics & Astronomy in Penn Arts and Sciences are now learning how head of bed (HOB) positioning affects blood flow reaching the brain. Most patients admitted to the hospital with an acute stroke are kept flat for at least 24 hours in an effort...

2014-03-21 12:24:07

HARRISBURG, Pa., March 21, 2014 /PRNewswire/ -- New research from United Concordia Dental continues to show that significant medical costs savings and reduced hospitalizations are possible when individuals with certain medical diseases or conditions, such as heart disease, stroke, or pregnancy, treat their gum disease. United Concordia's new study involved more than 338,891 individuals over a five-year period (2005-2009) with both Highmark medical insurance and United Concordia...


Latest stroke Reference Libraries

Stroke
2012-05-02 19:35:56

Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...

More Articles (1 articles) »
Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related